Market revenue in 2023 | USD 1,533.1 million |
Market revenue in 2030 | USD 2,805.4 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Immunohistochemistry |
Fastest growing segment | Digital Pathology and Workflow |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 25.71% in 2023. Horizon Databook has segmented the Asia Pacific tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific market of tissue diagnostics is expected to witness fastest growth over the forecast period. The major factors contributing to this growth are large untapped markets of emerging economies in the region. The market is majorly driven due to rise in cancer incidence across the region.
According to The Cancer Atlas, eastern, southern, and southeastern Asia contributes to 44% of the global cancer cases and 51% of the cancer deaths. China dominates the cancer burden in the region followed by India, Japan, Indonesia, and Republic of Korea.
Top thee applications for cancer tissue diagnostics in the region include breast cancer, lung cancer, and prostate cancer. However, Japan is technologically well versed and the penetration and adoption of benchtop analyzers is higher in Japan, thus attributing to larger share in this market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific tissue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account